---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-030523"
form_type: "8-K"
ticker: "PRVA"
cik: "0001759655"
company_name: "Privia Health Group, Inc."
filed_at: "2022-11-21T23:59:59+00:00"
generated_at: "2026-06-21T15:09:24.747620+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Privia Health selling stockholders complete 5.75M share secondary offering, no proceeds to company

## Summary
- Selling stockholders sold 5,000,000 firm shares plus 750,000 option shares (total 5.75M) in underwritten public offering.
- Company received no proceeds from the secondary sale; all shares sold by existing stockholders.
- Underwriting agreement with Goldman Sachs & Co. LLC included customary representations and indemnification.
- Offering closed on November 21, 2022; 30-day underwriter option exercised in full on November 18.

## SEC filing metadata
- accession: 0001628280-22-030523
- form_type: 8-K
- ticker: PRVA
- cik: 0001759655
- company_name: Privia Health Group, Inc.
- filed_at: 2022-11-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1759655/000162828022030523/0001628280-22-030523-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1759655/000162828022030523/prva-20221116.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-030523
- JSON: https://secwatch.observer/filing/0001628280-22-030523.json
- Plain text: https://secwatch.observer/filing/0001628280-22-030523.txt

## Key facts
- Material Agreements
  Privia Health Group, Inc. entered into Underwriting Agreement with Goldman Sachs & Co. LLC valued at 5,000,000 shares of common stock (plus up to 750,000 additional shares over-allotment) (effective 2022-11-16).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Goldman Sachs & Co. LLC
  - Value: 5,000,000 shares of common stock (plus up to 750,000 additional shares over-allotment)
  - Effective: 2022-11-16
  source text: On November 16, 2022, Privia Health Group, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC, in its capacity as the representative of the several underwriters listed on Schedule I thereto (in such capacity, the “Representative”) and the selling stockholders listed on Schedule II thereto (the “Selling Stockholders”) with respect to an underwritten offering by the Selling Stockholders of 5,000,000 shares (the “Firm Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), held by such Selling Stockholders. In addition, the underwriters were granted a 30-day option to purchase up to 750,000 additional shares (the “Optional Shares” and, together with the Firm Shares, the “Shares”) of Common Stock from the Selling Stockholders at the public offering price, less underwriting discounts and commissions, which the underwriters exercised in full on November 18, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1759655/000162828022030523/0001628280-22-030523-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.